Likopo tsa Clinical tsa Salmon PDRN ho Aesthetic Medicine: Ka Ntle ho Tlaleho ea "Salmon Sperm" 

Tlhaloso ea Meta
Lekola mahlale a ka morao ho Salmon PDRN bakeng sa ho hlaphoheloa kamora laser, taolo ea ho ruruha, le litharollo tse thibelang botsofali. Tataiso e sebetsang bakeng sa li-brand tsa skincare le litsebi tsa botle ba bongaka.

Selelekela: Hobaneng ha PDRN e Batla ho Shebelloa ha Bobeli

Ka Pherekhong 2026, sehlooho se ile sa boela sa hapa tlhokomelo ea lefatše la botle: “’Nete ka Lifahleho tsa Peō ea Salmon” . E ne e le ntho e tsosang takatso, ea kokoana-hloko, 'me-joaloka linako tse ngata tsa kokoana-hloko-e ne e sa utloisise ka ho feletseng.

Ka morao ho lebitso le qholotsang ho na le le leng la a mangata ka ho fetisisa li-biomolecules tse nchafatsang ka mokhoa o ikhethileng ho kena meriana ea botle ka lilemo tse mashome. Polydeoxyribonucleotide (PDRN) ha se feela motsoako o mong oa hydrating kapa collagen booster. E sebetsa ka litsela tse peli, tse bapileng-ts'ebetso ea li-extracellular receptor le intracellular nucleotide salvage-hore ho se be le motsoako o mong oa botle o ka etsisang .

Leha ho le joalo pherekano e ntse e tsoela pele. Lingaka li kopanya PDRN le polynucleotide (PN). Brands e rekisa "DNA skincare" ntle le ho utloisisa limolek'hule tsa boima ba 'mele. Batsamaisi ba China le U.S. ba tsamaea ka mekhahlelo e fapaneng, ba baka mathata a ho lumellana le ho qalisoa ha lihlahisoa lefatšeng ka bophara .

Sengoliloeng sena se ngoletsoe baetsi ba lihlahisoa, batsamaisi ba tleliniki, le litsebi tsa maano ba hlokang ho sutha ka nqane ho moferefere. Re hlahloba:

• The Mokhoa oa ho amohela A2A e khethollang PRN ho PN le lintlha tsa kholo

• Bopaki bo tobileng ba mokhoa bakeng sa lisebelisoa tsa post-laser le microneedling

• Phetoho ea mabitso-Hobaneng "Marques Polynucleotide Cutoff" e fetola mokhoa oa ho beha lihlahisoa

• Mehato ea bohlokoa ea taolo Chaena le seo ba se bolelang bakeng sa ho kena 'marakeng ka 2026-2027

Ha ho sensationalism. Ha ho lipolelo tsa "mohlolo". Sesupo feela, se arohaneng le lerata.

1. Ho Hlalosa Molek'hule: Ke Hobane'ng ha PDRN le PN li sa Fetohane

1.1 Ts'ebetso ea 2025 ea Nomenclature

Ka lilemo tse mashome a mararo, ho ne ho sebelisoa lingoliloeng tsa bokhabane PDRN le PN ka ho fapanyetsana. Ka bobeli li tsoa ho DNA. Ka bobeli li tsoa salmon kapa trout. Ka bobeli li sebelisoa ho li-injection le li-topical.

Sena e ne e le bothata. Baoki ba ile ba khetha lihlahisoa tse ipapisitseng le botumo ba mofuta ho fapana le ho tšoaneleha ha limolek'hule, e leng se lebisang ho sephetho se tlase le lingoliloeng tse ferekaneng tsa bongaka .

Ka Pherekhong 2025, sehlopha sa lipatlisiso sa machabeng se etelletsoeng pele ke Marques et al. e hlahisitse tharollo ea sebopeho: Marques Polynucleotide Cutoff.

• PDRN (Polydeoxyribonucleotide): Boima ba molek'hule <1500 kDa. Ketane e khuts'oane. A2A receptor agonist. Mokhoa oa mantlha: pontšo ea pharmacologic + nucleotide salvage.

• PN (Polynucleotide): Boima ba molek'hule ≥ 1500 kDa. Liketane tse telele. E etsa viscous hydrogel. Mokhoa oa mantlha: mechanical volumizing + hydration .

Phello ea bongaka:
Haeba sehlahisoa sa hau se itšetlehile ka anti-inflammatory signaling, fibroblast activation, kapa VEGF-mediated angiogenesis, u sebelisa PDRN—ho sa tsotellehe hore na leibole e re’ng. Haeba sehlahisoa sa hau se itšetlehile ka ho tlatsoa ha viscoelastic le hydration e tsitsitseng, o sebelisa PN .

1.2 Liphapang tsa Sebopeho tse Amang Ts'ebetso

Lintlha tsa bohlokoa bakeng sa lihlahisoa:
Ho sebelisa "PN" ho hlalosa mokhoa o khutšoanyane oa PDRN ha o fosahetse feela - o khelosa lingaka mabapi le mokhoa o lebelletsoeng le nako ea phello.

2. Mekhoa ea Ts'ebetso: Tsela e Mebeli e Hlalosang PDRN

Ho fapana le li-biomolecules tse ngata tse ntle tse sebetsang litlamorao tsa axis e le 'ngoe, PRN e sebetsa ka ho litsela tse peli tse ikemetseng empa tse kopanetsoeng .

2.1 Tsela ea Pele: Tšebeliso ea A2A ea ho amohela

PDRN ke agonist ea khethang ea Adenosine A2A receptor—Seamoheli sa G-protein-comupled se hlahisoang ho fibroblasts, lisele tsa endothelial, le lisele tsa 'mele tsa ho itšireletsa mafung.

Li-triggers tse tlamang:

• ↑ kampo (cyclic adenosine monophosphate) - lets'oao la intracellular hore ts'ebetso ea A2A e etsahetse

• ↓ Phetolelo ea NF-κB-e fokotsa ho ngoloa ha li-cytokine tse nang le pro-inflammatory (TNF-α, IL-1β, IL-6)

• ↑ VEGF (vascular endothelial growth factor) -e khothalletsa angiogenesis le phallo ea limatlafatsi ho folisa lisele

• ↑ Tšimoloho ea Collagen I/III-e kenelletse ka ho theola MMP-1 le ho phahamisoa ha TGF-β

Bopaki bo tsoang masimong a haufi:
A 2025 ScienceDirect boithuto bo mabapi le lefu la ho ruruha ha ulcerative bo netefalitse seo tsamaiso e kopanetsoeng ea DMPX (mohanyetsi oa A2A) felisitsoe ka botlalo Litlamorao tse khahlanong le ho ruruha le VEGF tsa PDRN. Ona ke ona mochine oa li-receptor o kentsoeng tšebetsong ho dermal fibroblasts .

Phetolelo ea bongaka:
Ha PDRN e tlisoa letlalong le senyehileng - ebang ke ka ente, microneedling, kapa infusion e thusoang ke laser - e bontša hore lisele li fetoha ho tloha ho ho ruruha ho ea ho mokhoa oa ho lokisa. Sena ha se phepo e nepahetseng feela. Sena ke ho kenella ka pharmacologic .

2.2 Tsela ea Bobeli: Savage Pathway Nucleotide Supply

Li-tissue tse lemetseng le tsa hypoxic li tobane le bothata ba matla. E boetse e bitsoa nucleotide synthesis—mokhoa oa kamehla oa sele oa ho etsa li-precursor tsa DNA—o sebelisa oksijene e ngata ebile o turu haholo .

PRN e fana ka mokhoa o mong.

Ha PDRN e oela ho senyeha ha enzymatic, e lokolloa bioavailable nucleosides le nucleotide tse kenang ho tsela ea ho pholosa. Sena se sebelisa hape metheo e entsoeng esale pele ka kotloloho ho motsoako oa DNA, ho feta tsela e bitsang matla a matla a novo .

Hobaneng sena se le bohlokoa ho tsa bongaka ba aesthetic:

• Letlalo la post-laser le khatello ea methapo ea kutlo le hypoxic

• Li-fibroblasts li hloka li-nucleotide ho ata le ho etsa collagen

• PRN e fana ka lihlahisoa tse tala hanghang ha ka nako e le 'ngoe e tšoaea ka A2A ho ntlafatsa mechine ea ho lokisa

Ha ho na motsoako o mong oa botle o etsang ka bobeli.

3. Likopo tsa Clinical: Bopaki ka Tsamaiso

3.1 Post-Laser Resurfacing: Pontšo e Tšehetsoang ka ho Fetisisa

Bothata:
Fractional laser resurfacing e baka kotsi e laoloang ea mocheso. Le hoja e sebetsa bakeng sa ho nchafatsa, e susumetsa nako e telele ea erythema, edema, le ho fokotseha ha mokuli. Ho ea ka nalane, lingaka li ile tsa amohela sena e le ntho e ke keng ea qojoa .

Tlhaloso ea PDRN:
Boithuto ba mohlala oa likhoto ka 2017 ke Yu le Lee bo bontšitse seo Maqeba a laser a phekoloang ke PDRN a bontšitse lisele tse ntle tsa VEGF le li-microvessels tse nang le CD31. bapisoa le ditaolo. Re-epithelialization e potlakile. Ho ruruha ho ile ha kokobela kapele .

perela ea bongaka:
PDRN ha e "thibele" kotsi ea laser-e e hatella mohato oa ho ruruha le e holisa mokhahlelo oa ho ata. Bakuli ba ntse ba redden, empa ba tsoa ka bokgubedu kapele .

Tlhaloso ea protocol ea 2026:
Litliliniki tse etellang pele tsa ho nchafatsa tsa US hona joale li sebelisa PDRN joalo ka keketso ea boikhethelo ho phahamisa sefahleho le mekhoa ea laser-eseng e le "mohlolo" o ikemetseng, empa e le a sentlafatso ya modumo wa baeloji ea tikoloho ea pholiso .

3.2 Microneedling e nang le PDRN: Synergy-Assisted Synergy

Microneedling e theha li-microchannel tse otlolohileng e fetang mokoallo oa stratum corneum. Hona ha se ho fana ka puo feela—ho fana ka puo micro-injury ka boeona e kenya liplatelete 'me e hira lisele tse lokisang .

Ha PDRN e e kentsoeng nakong ea microneedling, mekhoa e 'meli e tsamaisana:

1. 'Mele: PDRN e fihla dermis ntle le ho itšetleha ka mekhoa e belaetsang ea "transdermal".

2. Likokoana-hloko: Ho ruruha ho bakoang ke Microneedling ke ka mafolofolo modulated ka PDRN's A2A agonism

Liphetho tse shebiloeng (li tlalehile tleliniking):

• Nako ea erythema e fokotsehileng ka mor'a ts'ebetso

• Ho khutlela ho litlolo ka potlako (hangata lihora tse 24 khahlano le 48–72)

• Khatelo-pele e ntlafalitsoeng ea sebopeho nakong ea li-session tsa 3-6

Tlhokomeliso:
Topical PDRN e sebelisoa letlalong le sa fetoheng ntle le ho fana ka thuso ho ntse ho se na bopaki ba katleho. Lingaka tsa letlalo tseo ho buisanoeng le tsona ka Hlakola 2026 li bontšitse lipelaelo tsa hore melemo e bonahalang ho tsoa ho li-serum tsa "lapeng" tsa PDRN li tsoa ho PDRN ka boeona -metsoako e tšehetsang e ka 'na ea e-ba baemeli ba' nete ba sebetsang .

3.3 Likopo tse Khahlanong le ho Ruruhisa: Ka Ntle ho Ts'ebetso ea Ka mor'a

Ho ruruha ho sa foleng ha maemo a tlase ho tšoaea letlalo le tsofalang, letlalo le utloang bohloko, le li-phenotypes tse tloaelehileng tsa rosacea. Liente tsa khale tse thibelang ho ruruha (corticosteroids, calcineurin inhibitors) lia sebetsa empa ha li tšoanelehe bakeng sa tlhokomelo ea nako e telele .

PRN e fana ka a e seng steroidal, e laoloang ke fisioloji mochine o thibelang ho ruruha.

Phatlalatso ea bopaki:

• Ketso ea A2A e hatella NF-κB, e fokotsa ho ngoloa ha TNF-α le IL-6

• IL-10 (anti-inflammatory cytokine) e laoloa

• Tlhahiso ea VEGF e tšehetsa botšepehi ba vascular, e fokotsa erythema e tsitsitseng

Sepheo sa tleliniki:
Bakuli ba sa khoneng ho mamella li-retinoids ka lebaka la bofokoli ba lithibelo ba ka rua molemo ho tsona PDRN e le moemeli oa tlhokomelo ea pro-reparative, e sebelisoang hammoho le ho tlotsa hamonate le photoprotection .

4. Boemo ba Taolo: Boemo ba 2026 le Liphello tsa Leano

4.1 China: Melemo ea NMPA

Ho tloha ka Mmesa 2025, lik'hamphani tse supileng feela o ne a qetile ho ngolisa faele e kholo ea sesebelisoa sa bongaka sa PDRN le NMPA ea Chaena. Lingmei Biotechnology (Hubei Lingmei) e ile ea e-ba eona ea bosupa ka la 16 Mmesa, 2025 .

Lenane la nako:

• Ngoliso e kholo ea faele: 2025 Q2

• Ho phetheloa ha liteko tsa tleliniki: Khakanyo ea 2025 Q3

• Tumello e reriloeng ea sesebelisoa sa bongaka sa Sehlopha sa III: 2026 Q4

Sena se bolela eng:

• Ha ho na PDRN e lumellanang le ente e fumanehang Chaena

• Lihlahisoa tse rekisoang li itšetlehile ka ngoliso ea litlolo kapa marang-rang a marang-rang a marang-rang a marang-rang

• Lihlahisoa tsa pele tse nang le lisebelisoa tse amohetsoeng tsa Sehlopha sa III li tla hapa karolo ea bohlokoa ea mmaraka bofelong ba 2026

Nts'etsopele e tšoanang:
SEOHO LAB e phethetse ngoliso ea laesense ea bohloeki ea NMPA bakeng sa Litšobotsi tsa PDRN ka Tšitoe 2025, ho tlosa lithibelo tsa kantle ho naha bakeng sa setlolo-mophato Lihlahisoa tsa PRN.

Ntho ea bohlokoa ka ho fetisisa:
PDRN e nang le ente le topical PDRN ke litsela tse fapaneng tsa taolo. Li-brand tse shebileng likanale tsa bongaka li tlameha ho etelletsa pele Ngoliso ea lisebelisoa tsa Sehlopha sa III. Li-brand tse shebileng liteishene tsa bareki li ka tsoela pele ka Tsebiso ea litlolo tsa NMPA, empa o tlameha ho qoba ho etsa lipolelo tse kang tsa lithethefatsi .

4.2 United States: Boemo ba FDA

Ha ho sehlahisoa sa PDRN se nang le ente se lumelletsoeng ke FDA bakeng sa tšebeliso ea botle .

Tšebeliso ea bongaka e etsahala off-label, hangata ke lingaka tse:

• Kenya lihlahisoa tlas'a mekoloto ea tšebeliso ea hau

• Motsoako oa PDRN maemong a pharmacy

• Sebelisa li-microneedling-assisted topical delivery (tse sa boleleng tšebeliso ea ente)

Tlhokomelo ea letlalo ea PDRN e laoloa e le setlolo 'me ha e hloke tumello ea pele ea FDA. Leha ho le joalo, the FDA ha e so thehe monograph bakeng sa PDRN, le litekanyetso tsa boima ba limolek'hule ha li eo—ho bolelang hore lihlahisoa tse peli tse ngotsoeng “PDRN serum” e kanna ea ba le likaroloana tse fapaneng ka ho felletseng .

5. Mehopolo ea Tlhahiso bakeng sa Brands le Baetsi

5.1 Boima ba Limolek'hule: Phapang e Patehileng

Marques Cutoff (1500 kDa) ke maemo a mabitso, eseng a tlhaloso ea sebopeho. Matla a bophelo bo botle a ipapisitse le ho ajoa ha likhechana, eseng feela ka karolelano boima ba molek'hule .

Bopaki ba 2018:
Hwang et al. bontshitse seo mefuta e mengata e sebetsang ea likaroloana tsa PDRN e bohlokoa bakeng sa boleng ba ho folisa maqeba. E khutšoanyane haholo: ho senyeha ka potlako, ha ho na pontšo e tsitsitseng. Nako e telele haholo: ho fokotsoa ha bioavailability ea A2A, boitšoaro ba mochini bo tšoana le PN .

Tataiso ea ho theha:

• Kopa tlhahlobo e felletseng ea kabo ea likhechana ho tsoa ho bafani ba thepa e tala

• Hana lintlha tse thathamisang "boima bo tloaelehileng ba molek'hule"

• Bakeng sa matšoao a tokiso ea kamora ts'ebetso, likhechana tsa ketane e mahareng (50–500 kDa) e ka fana ka likamano tse nepahetseng tsa A2A

5.2 Tsamaiso ea Phano: Bohlokoa ba ho Monya

PRN ke hydrophilic le boima bo phahameng ba molek'hule bo amanang le mesebetsi ea setso ea litlolo. Phatlalatso e sa sebetseng ka stratum corneum e fokola haholo.

Mekhoa e netefalitsoeng ea ho tlisa thepa:

Tlhaloso ea lebitso:
Haeba u qala "serum ea PDRN ea lapeng," u tlameha kapa:

1. Tsetela ho bioavailable fragment engineering (likaroloana tse tlase haholo tsa MW), kapa

2. Amohela seo metsoako ea koloi (li-humectants, anti-inflammatories) li tsamaisa melemo ea hang-hang ea litlolo, 'me PDRN e kenya letsoho. litlamorao tse bokellaneng tsa ho nchafatsa ka libeke ho isa ho likhoeli .

6. Meeli e Hlahang le Lipotso Tse sa Rarolloang

6.1 Vegan / Recombinant PDRN

PDRN ea setso ke e entsoeng ka salmon. Matšoenyeho a tikoloho, melaoana ea phepelo ea thepa, le likhohlano tsa phepelo ea litlhapi li ekelitse thahasello ho mefuta e meng e thehiloeng ho semela le ho belisoa .

Boemo ba hajoale:

• Vegan PDRN (e tsoang ho algae, bioloji ea maiketsetso) e fumaneha khoebong

• Mechanism ke e etselitsoeng ho etsisa A2A agonistism

• Lintlha tsa nako e telele tsa kliniki ha li so fumanehe

Pono ea dermatologist:
"Liphetolelo tsa vegan li hula lisebelisoa tse tšoanang letlalong 'me li fana ka melemo e tšoanang le ea setso sa salmon PDRN, empa ha ba na lintlha tsa nako e telele tsa kliniki tse li tšehetsang." — Nicole Lee, MD

6.2 PDRN ka Liphekolo Tse Kopanetsoeng

Bokamoso ba PDRN bo ka etsahala motsoako, eseng monotherapy.

Likopano tse hlahang:

• PDRN + Exosomes: Sistimi ea AnteAGE's P.E.A.R.L e kopanya PDRN le limolek'hule tsa exosome bakeng sa ts'ebeliso ea post-microneedling.

• PDRN + Hyaluronic Acid: E hlahlojoa ka likopo tse kopanetsoeng le tsa dermal; Synergy e bonoang ho ata ha fibroblast

• PDRN + Lintlha tsa Kholo: Theory synergy; lintlha tse fokolang tse hatisitsoeng

Mabaka a bongaka:
PRN e fana ka karolo ea nucleotide le Letšoao la A2A. Li-exosomes le lintlha tsa kholo li fana ka litaelo tse eketsehileng tsa cytokine. Tsena ke tlatsanang, ha ho hlokahale .

6.3 Phetoho ea Nomenclature: Phetoho ea Khoebo

The Marques Cutoff ke ka tlase ho selemo. Ho nkeloa ka lapeng litokomaneng tsa taolo, lipharmacopeia, le lintlha tsa khoebo ho tla nka nako .

Kotsi bakeng sa mefuta:

• Ho tsoelapele ho ngola PDRN e mahareng e le "PN" e kanna ea mema tlhatlhobo ya taolo ha litlhaloso li tiisa

• Ho tseka "PDRN" bakeng sa likhechana tse kaholimo ho 1500 kDa ho hanana le maemo a hlahang.

• INCI nomenclature ha e so ntlafatsoe; bokgoni ba khoebo bo tla rata batho ba qalang ho sebelisa mantsoe a nepahetseng

Qetello: PRN in the 2026-2027 Treatment Landscape

PDRN e entsoeng ka salmon ha se feshene. E tšehetse lilemo tse mashome a mararo tsa tlhokomelo ea nako le nako ea kliniki hobane mochine oa eona o biologically fundamental, eseng ho itshetleha ka mokgwa .

PDRN ke eng:

• Ntho e nchafatsang litsela tse peli e nang le e bontšitse A2A agonism le salvage pathway bioactivity

• A accelerator ka morao ho ts'ebetso e tšehetsoang ke bopaki ba liphoofolo le bo fetoletsoeng

• A motsoako o fapaneng ka phapang e hlakileng ea limolek'hule ho tloha ho PN

Seo PDRN e seng sona:

• “Mohlolo” o phahamisa sefahleho o le mong

• FDA-e amohetsoe bakeng sa ente ea botle ho la U.S.

• Sehlahisoa se tloaelehileng-litaba tsa kabo ea likaroloana

Bakeng sa litsebi tsa botle ba bongaka:

• Lekola PDRN joalo ka tlatsetso, eseng ho nkela sebaka

• Beha lintho tse tlang pele thuso ya pelehi (microneedling, laser) holim'a ts'ebeliso e sa sebetseng ea lihlooho

• Lula u tseba Litumello tsa Sehlopha sa III sa NMPA- ba tla fetola 'maraka oa Asia ka 2026-2027

Bakeng sa li-brand tsa skincare:

• Hlahloba lebitso la hau la mabitso. Na u rekisa PRN kapa PN? Na u ka e paka?

• Haeba e qala China, arola maano a hau a ho laola ka ente le litlolo

• Haeba o qala PDRN ea vegan, e be pepeneneng mabapi le ho ba sieo ha data nako e telele bapisa

Lihlooho tsa litaba tsa "salmon sperm" li tla tsoela pele. Ba etsa joalo kamehla.

Ka mor'a bona, biomolecule e nepahetseng e bokella bopaki ka khutso, e ntlafatsa tlhaloso ea eona, 'me e itokisetsa mohato o latelang oa kholo ea bongaka.

PDRN e tšoaneloa ke botle ho feta botumo ba kokoana-hloko. E lokeloa ke ts'ebeliso e nepahetseng, ho ngolisoa ka 'nete, le ho kopanngoa ho liprothokholo tse nchafatsang tse hlomphang bokhoni ba eona le meeli ea eona.